These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Gedik Y; Orhan F Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792 [TBL] [Abstract][Full Text] [Related]
4. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Khellaf M; Michel M; Schaeffer A; Bierling P; Godeau B Haematologica; 2005 Jun; 90(6):829-32. PubMed ID: 15951296 [TBL] [Abstract][Full Text] [Related]
5. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases. Baronci C; Petrone A; Miano C; Lombardi A; Caniglia M; Russo LA; Luciani M; Pinto RM; Rana I; Caruso R; De Rossi G Ann Ist Super Sanita; 1998; 34(4):457-61. PubMed ID: 10234876 [TBL] [Abstract][Full Text] [Related]
8. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). O'Brien SH; Ritchey AK; Smith KJ Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529 [TBL] [Abstract][Full Text] [Related]
9. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522 [TBL] [Abstract][Full Text] [Related]
10. [Splenectomy in adult patients with idiopathic thrombocytopenic purpura after intravenous immunoglobulin treatment]. Nowak T; Kucharski W; Scharf R Acta Haematol Pol; 1994; 25(1):31-5. PubMed ID: 8209611 [TBL] [Abstract][Full Text] [Related]
11. [Auto-immune idiopathic thrombocytopenic purpura in children. Apropos of 100 cases]. Pladys P; Bergeron C; Bétrémieux P; Goasguen J; Fremond B; Le Gall E Pediatrie; 1993; 48(3):181-8. PubMed ID: 8393973 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
14. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
15. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
16. Acute immune thrombocytopenic purpura. To treat or not to treat? Bolton-Maggs P Hamostaseologie; 2009 Jan; 29(1):74-5. PubMed ID: 19151852 [TBL] [Abstract][Full Text] [Related]